DAVID M MOTT Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for DAVID M MOTT.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of DAVID M MOTT. DAVID M MOTT is Vice Chairman and CEO in MEDIMMUNE INC /DE ($MEDI) and Director in NOVAVAX INC ($NVAX) and 10% Owner in ARCA biopharma, Inc. ($ABIO) and 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in AVEO PHARMACEUTICALS INC ($AVEO) and 10% Owner in MULESOFT, INC ($MULE) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Cascadian Therapeutics, Inc. ($CASC) and 10% Owner in Care.com Inc ($CRCM) and Director in ARDELYX, INC. ($ARDX) and 10% Owner in APPIAN CORP ($APPN) and Director in Mersana Therapeutics, Inc. ($MRSN) and 10% Owner in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Roka BioScience, Inc. ($ROKA) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and Director in TESARO, Inc. ($TSRO) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and Director in Epizyme, Inc. ($EPZM) and Director in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in IMARA Inc. ($IMRA) and 10% Owner in Elastic N.V. ($ESTC) and Director in Nightstar Therapeutics plc ($NITE) and 10% Owner in Surface Oncology, Inc. ($SURF) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM).

Latest Insider Trading Transactions of DAVID M MOTT

Sentiment: All, AKAO, ADAP, APPN, ABIO, ARDX, AVEO, CRCM, CASC, CERC, ESTC, EPZM, GNCA, IMRA, ILIU, MEDI, MRSN, MIRM, MULE, NITE, NVAX, RARX, RGLS, RYTM, ROKA, SURF, SYBX, TSRO, TCON, TRVI

Page: < prev 1 2

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 27 2018	TCON	Tracon Pharmaceuti ...	MOTT DAVID M	10% Owner	Buy	P	2.70	707,964	1,911,503	3,466,003	2.8 M to 3.5 M (+25.67 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	MOTT DAVID M	Director	Buy	P	1.95	294,090	572,358	73,407,508	73.1 M to 73.4 M (+0.40 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	MOTT DAVID M	Director	Buy	P	1.90	869,574	1,655,669	73,113,418	72.2 M to 73.1 M (+1.20 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	MOTT DAVID M	Director	Buy	P	1.81	104,844	189,820	72,243,844	72.1 M to 72.2 M (+0.15 %)
Mar 13 2018	CASC	Cascadian Therapeu ...	MOTT DAVID M	10% Owner	Sell	U	0.00	10,882,574	0	0	10.9 M to 0 (-100.00 %)
Mar 06 2018	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Buy	P	59.82	3,159	188,957	739,516	736.4 K to 739.5 K (+0.43 %)
Mar 06 2018	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Buy	P	59.76	4,311	257,643	736,357	732 K to 736.4 K (+0.59 %)
Mar 06 2018	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Buy	P	59.15	400	23,658	732,046	731.6 K to 732 K (+0.05 %)
Mar 06 2018	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Buy	P	58.28	7,557	440,433	731,646	724.1 K to 731.6 K (+1.04 %)
Mar 06 2018	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Buy	P	57.34	4,465	256,043	724,089	719.6 K to 724.1 K (+0.62 %)
Mar 06 2018	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Buy	P	56.66	1,020	57,794	719,624	718.6 K to 719.6 K (+0.14 %)
Mar 06 2018	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Buy	P	55.01	1,600	88,015	718,604	717 K to 718.6 K (+0.22 %)
Mar 06 2018	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Buy	P	54.32	6,575	357,165	717,004	710.4 K to 717 K (+0.93 %)
Mar 06 2018	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Buy	P	59.82	12,634	755,708	9,681,129	9.7 M to 9.7 M (+0.13 %)
Mar 06 2018	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Buy	P	59.76	17,248	1,030,813	9,668,495	9.7 M to 9.7 M (+0.18 %)
Mar 06 2018	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Buy	P	59.15	1,600	94,634	9,651,247	9.6 M to 9.7 M (+0.02 %)
Mar 06 2018	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Buy	P	58.28	30,321	1,767,153	9,649,647	9.6 M to 9.6 M (+0.32 %)
Mar 06 2018	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Buy	P	57.34	17,859	1,024,114	9,619,326	9.6 M to 9.6 M (+0.19 %)
Mar 06 2018	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Buy	P	56.66	4,080	231,174	9,601,467	9.6 M to 9.6 M (+0.04 %)
Mar 06 2018	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Buy	P	55.01	6,399	352,005	9,597,387	9.6 M to 9.6 M (+0.07 %)
Mar 06 2018	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Buy	P	54.32	26,304	1,428,875	9,590,988	9.6 M to 9.6 M (+0.28 %)
Feb 27 2018	ABIO	ARCA biopharma, In ...	MOTT DAVID M	10% Owner	Sell	S	0.50	1,460,209	731,273	0	1.5 M to 0 (-100.00 %)
Feb 15 2018	APPN	APPIAN CORP	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	2,724,202	0	0
Feb 15 2018	APPN	APPIAN CORP	MOTT DAVID M	10% Owner	Buy	J	0.00	679	0	2,031	1.4 K to 2 K (+50.22 %)
Feb 15 2018	APPN	APPIAN CORP	MOTT DAVID M	10% Owner	Buy	J	0.00	4,946	0	13,895	8.9 K to 13.9 K (+55.27 %)
Feb 15 2018	APPN	APPIAN CORP	MOTT DAVID M	10% Owner	Buy	J	0.00	1,352	0	1,352	0 to 1.4 K
Feb 15 2018	APPN	APPIAN CORP	MOTT DAVID M	10% Owner	Buy	J	0.00	8,949	0	8,949	0 to 8.9 K
Feb 15 2018	APPN	APPIAN CORP	MOTT DAVID M	10% Owner	Sell	J	0.00	13,621	0	0	13.6 K to 0 (-100.00 %)
Feb 15 2018	APPN	APPIAN CORP	MOTT DAVID M	10% Owner	Buy	J	0.00	13,621	0	13,621	0 to 13.6 K
Feb 15 2018	APPN	APPIAN CORP	MOTT DAVID M	10% Owner	Sell	J	0.00	27,242	0	0	27.2 K to 0 (-100.00 %)
Feb 15 2018	APPN	APPIAN CORP	MOTT DAVID M	10% Owner	Buy	J	0.00	27,242	0	27,242	0 to 27.2 K
Feb 15 2018	APPN	APPIAN CORP	MOTT DAVID M	10% Owner	Sell	J	0.00	2,724,202	0	0	2.7 M to 0 (-100.00 %)
Feb 15 2018	APPN	APPIAN CORP	MOTT DAVID M	10% Owner	Buy	C	0.00	2,724,202	0	2,724,202	0 to 2.7 M
Jan 26 2018	MIRN	SYNLOGIC, INC.	MOTT DAVID M	10% Owner	Grant	A	9.75	410,000	3,997,500	4,228,940	3.8 M to 4.2 M (+10.74 %)
Jan 04 2018	MRSN	Mersana Therapeuti ...	MOTT DAVID M	Director	Option Exercise	A	17.39	6,611	114,965	6,611
Nov 27 2017	APPN	APPIAN CORP	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	569,620	0	2,724,202
Nov 27 2017	APPN	APPIAN CORP	MOTT DAVID M	10% Owner	Sell	S	19.49	569,620	11,101,894	0	569.6 K to 0 (-100.00 %)
Nov 27 2017	APPN	APPIAN CORP	MOTT DAVID M	10% Owner	Buy	C	0.00	569,620	0	569,620	0 to 569.6 K
Nov 21 2017	APPN	APPIAN CORP	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	2,820,516	0	3,293,822
Nov 21 2017	APPN	APPIAN CORP	MOTT DAVID M	10% Owner	Sell	S	19.49	2,820,516	54,971,857	0	2.8 M to 0 (-100.00 %)
Nov 21 2017	APPN	APPIAN CORP	MOTT DAVID M	10% Owner	Buy	C	0.00	2,820,516	0	2,820,516	0 to 2.8 M
Nov 08 2017	CRCM	Care.com Inc	MOTT DAVID M	10% Owner	Buy	J	0.00	2,302	0	2,302	0 to 2.3 K
Nov 08 2017	CRCM	Care.com Inc	MOTT DAVID M	10% Owner	Buy	J	0.00	504	0	504	0 to 504
Nov 08 2017	CRCM	Care.com Inc	MOTT DAVID M	10% Owner	Sell	J	0.00	10,000	0	0	10 K to 0 (-100.00 %)
Nov 08 2017	CRCM	Care.com Inc	MOTT DAVID M	10% Owner	Buy	J	0.00	10,000	0	10,000	0 to 10 K
Nov 08 2017	CRCM	Care.com Inc	MOTT DAVID M	10% Owner	Sell	J	0.00	1,000,000	0	2,256,013	3.3 M to 2.3 M (-30.71 %)
Oct 10 2017	RYTM	RHYTHM PHARMACEUTI ...	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	2,927,708	0	0
Oct 10 2017	RYTM	RHYTHM PHARMACEUTI ...	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	1,402,870	0	0
Oct 10 2017	RYTM	RHYTHM PHARMACEUTI ...	MOTT DAVID M	10% Owner	Buy	P	17.00	550,000	9,350,000	4,909,956	4.4 M to 4.9 M (+12.61 %)
Oct 10 2017	RYTM	RHYTHM PHARMACEUTI ...	MOTT DAVID M	10% Owner	Buy	C	0.00	2,927,708	0	4,359,956	1.4 M to 4.4 M (+204.41 %)
Oct 10 2017	RYTM	RHYTHM PHARMACEUTI ...	MOTT DAVID M	10% Owner	Buy	C	0.00	1,402,870	0	1,432,248	29.4 K to 1.4 M (+4,775.24 %)
Sep 18 2017	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Buy	P	15.25	200,000	3,050,000	6,054,351	5.9 M to 6.1 M (+3.42 %)
Aug 30 2017	MIRN	SYNLOGIC, INC.	MOTT DAVID M	10% Owner	Grant	A	0.00	3,394,439	0	3,818,940	424.5 K to 3.8 M (+799.63 %)
Jul 06 2017	MRSN	Mersana Therapeuti ...	MOTT DAVID M	Director	Option Exercise	C	0.00	2,216,626	0	0
Jul 06 2017	MRSN	Mersana Therapeuti ...	MOTT DAVID M	Director	Option Exercise	C	0.00	18,001,419	0	0
Jul 06 2017	MRSN	Mersana Therapeuti ...	MOTT DAVID M	Director	Option Exercise	C	0.00	11,931,173	0	0
Jul 06 2017	MRSN	Mersana Therapeuti ...	MOTT DAVID M	Director	Buy	P	15.00	1,000,000	15,000,000	8,140,138	7.1 M to 8.1 M (+14.01 %)
Jul 06 2017	MRSN	Mersana Therapeuti ...	MOTT DAVID M	Director	Buy	C	0.00	7,140,138	0	7,140,138	0 to 7.1 M
Jul 03 2017	ADAP	Adaptimmune Therap ...	MOTT DAVID M	Director	Option Exercise	A	0.75	302,561	226,921	302,561
Jun 26 2017	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Option Exercise	A	13.65	12,500	170,625	12,500
Jun 09 2017	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Option Exercise	A	4.30	15,000	64,500	15,000
Jun 09 2017	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Grant	A	0.00	19,534	0	33,877	14.3 K to 33.9 K (+136.19 %)
Jun 05 2017	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Option Exercise	A	149.22	12,000	1,790,640	12,000
Jun 05 2017	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Grant	A	0.00	676	0	12,825	12.1 K to 12.8 K (+5.56 %)
May 31 2017	APPN	APPIAN CORP	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	6,114,338	0	6,114,338
May 31 2017	APPN	APPIAN CORP	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	6,114,338	0	0
Mar 29 2017	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	0.50	6,000,000	3,000,000	16,362,694	10.4 M to 16.4 M (+57.90 %)
Mar 28 2017	ADAP	Adaptimmune Therap ...	MOTT DAVID M	Director	Buy	P	0.70	12,870,000	9,009,000	72,139,000	59.3 M to 72.1 M (+21.71 %)
Mar 22 2017	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Option Exercise	J	0.00	858,978	0	858,978
Mar 22 2017	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Option Exercise	J	0.00	2,576,939	0	2,576,939
Mar 22 2017	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Option Exercise	J	0.00	12,679,970	0	12,679,970
Mar 22 2017	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	227,125	0	0
Mar 22 2017	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	631,853	0	0
Mar 22 2017	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	681,377	0	0
Mar 22 2017	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	1,895,562	0	0
Mar 22 2017	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	605,668	0	0
Mar 22 2017	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	2,064,048	0	0
Mar 22 2017	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	8,000,038	0	0
Mar 22 2017	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	1,689,436	0	0
Mar 22 2017	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Sell	J	0.00	858,978	0	0	859 K to 0 (-100.00 %)
Mar 22 2017	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Buy	C	0.00	858,978	0	858,978	0 to 859 K
Mar 22 2017	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Sell	J	0.00	2,576,939	0	0	2.6 M to 0 (-100.00 %)
Mar 22 2017	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Buy	C	0.00	2,576,939	0	2,576,939	0 to 2.6 M
Mar 22 2017	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Sell	J	0.00	12,679,970	0	0	12.7 M to 0 (-100.00 %)
Mar 22 2017	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Buy	C	0.00	12,359,190	0	12,679,970	320.8 K to 12.7 M (+3,852.86 %)
Dec 19 2016	AKAO	Achaogen Inc	MOTT DAVID M	10% Owner	Buy	P	13.50	500,000	6,750,000	5,215,128	4.7 M to 5.2 M (+10.60 %)
Nov 29 2016	TCON	Tracon Pharmaceuti ...	MOTT DAVID M	10% Owner	Buy	P	5.75	869,565	4,999,999	2,758,039	1.9 M to 2.8 M (+46.05 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	4,362,472	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	4,689,657	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	12,447,605	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MOTT DAVID M	10% Owner	Option Exercise	X	0.07	80,658	5,646	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MOTT DAVID M	10% Owner	Buy	P	13.00	338,462	4,400,006	3,490,073	3.2 M to 3.5 M (+10.74 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MOTT DAVID M	10% Owner	Buy	C	0.00	623,210	0	3,151,611	2.5 M to 3.2 M (+24.65 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MOTT DAVID M	10% Owner	Buy	C	0.00	669,951	0	2,528,401	1.9 M to 2.5 M (+36.05 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MOTT DAVID M	10% Owner	Buy	C	0.00	1,778,227	0	1,858,450	80.2 K to 1.9 M (+2,216.60 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MOTT DAVID M	10% Owner	Sell	S	13.00	435	5,655	80,223	80.7 K to 80.2 K (-0.54 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MOTT DAVID M	10% Owner	Buy	X	0.07	80,658	5,646	80,658	0 to 80.7 K
Sep 23 2016	ROKA	Roka BioScience, I ...	MOTT DAVID M	10% Owner	Option Exercise	P	0.70	5,714,286	4,000,000	5,714,286
Sep 23 2016	ROKA	Roka BioScience, I ...	MOTT DAVID M	10% Owner	Option Exercise	P	0.70	4,000	2,800	4,000
Aug 12 2016	ADAP	Adaptimmune Therap ...	MOTT DAVID M	Director	Option Exercise	A	1.27	191,410	243,091	191,410
Aug 02 2016	ILIU	INTERLEUKIN GENETI ...	MOTT DAVID M	10% Owner	Option Exercise	P	0.10	20,120,724	2,000,000	20,120,724
Aug 02 2016	ILIU	INTERLEUKIN GENETI ...	MOTT DAVID M	10% Owner	Buy	P	0.10	20,120,724	2,000,000	55,418,811	35.3 M to 55.4 M (+57.00 %)
Jul 20 2016	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	P	8.73	763,650	6,666,665	2,665,519	1.9 M to 2.7 M (+40.15 %)
Jul 20 2016	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	P	8.73	763,651	6,666,673	2,665,520	1.9 M to 2.7 M (+40.15 %)
Jul 20 2016	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	P	8.73	763,650	6,666,665	2,665,519	1.9 M to 2.7 M (+40.15 %)
Jul 20 2016	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	P	8.73	763,651	6,666,673	2,665,520	1.9 M to 2.7 M (+40.15 %)
Jul 06 2016	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Grant	A	10.33	6,000	61,980	6,000	0 to 6 K
Jun 06 2016	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Option Exercise	A	9.27	15,000	139,050	15,000
Jun 06 2016	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Grant	A	0.00	8,522	0	14,343	5.8 K to 14.3 K (+146.40 %)
Jun 03 2016	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Option Exercise	A	47.27	12,000	567,240	12,000
Jun 03 2016	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Grant	A	0.00	2,115	0	12,149	10 K to 12.1 K (+21.08 %)
May 23 2016	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Option Exercise	A	9.33	12,500	116,625	12,500
Mar 18 2016	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Buy	P	35.19	710,429	24,999,997	710,429	0 to 710.4 K
Mar 18 2016	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Buy	P	35.19	710,429	24,999,997	9,564,684	8.9 M to 9.6 M (+8.02 %)
Jan 14 2016	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	P	10.00	500,000	5,000,000	1,901,869	1.4 M to 1.9 M (+35.67 %)
Jan 14 2016	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	P	10.00	500,000	5,000,000	1,901,869	1.4 M to 1.9 M (+35.67 %)
Jan 12 2016	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Buy	P	9.00	1,111,111	9,999,999	5,854,351	4.7 M to 5.9 M (+23.43 %)
Oct 20 2015	CERC	Cerecor Inc.	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	16,638,880	0	0
Oct 20 2015	CERC	Cerecor Inc.	MOTT DAVID M	10% Owner	Buy	C	0.00	594,245	0	594,245	0 to 594.2 K
Oct 06 2015	MIRN	Mirna Therapeutics ...	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	583,559	0	0
Oct 06 2015	MIRN	Mirna Therapeutics ...	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	1,241,650	0	0
Oct 06 2015	MIRN	Mirna Therapeutics ...	MOTT DAVID M	10% Owner	Buy	P	7.00	857,142	5,999,994	2,971,517	2.1 M to 3 M (+40.54 %)
Oct 06 2015	MIRN	Mirna Therapeutics ...	MOTT DAVID M	10% Owner	Buy	J	0.00	31,650	0	2,114,375	2.1 M to 2.1 M (+1.52 %)
Oct 06 2015	MIRN	Mirna Therapeutics ...	MOTT DAVID M	10% Owner	Buy	C	0.00	583,559	0	2,082,725	1.5 M to 2.1 M (+38.93 %)
Oct 06 2015	MIRN	Mirna Therapeutics ...	MOTT DAVID M	10% Owner	Buy	J	0.00	257,516	0	1,499,166	1.2 M to 1.5 M (+20.74 %)
Oct 06 2015	MIRN	Mirna Therapeutics ...	MOTT DAVID M	10% Owner	Buy	C	0.00	1,241,650	0	1,241,650	0 to 1.2 M
Jul 10 2015	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Option Exercise	A	22.78	7,333	167,046	7,333
Jun 12 2015	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Option Exercise	A	14.60	15,000	219,000	15,000
Jun 12 2015	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Grant	A	0.00	5,821	0	5,821	0 to 5.8 K
Jun 09 2015	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Option Exercise	P	13.91	420,561	5,850,004	420,561
Jun 09 2015	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Option Exercise	P	13.91	420,561	5,850,004	420,561
Jun 09 2015	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	P	10.70	1,401,869	14,999,998	1,401,869	0 to 1.4 M
Jun 09 2015	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	P	10.70	1,401,869	14,999,998	1,401,869	0 to 1.4 M
Jun 02 2015	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Option Exercise	A	60.77	10,000	607,700	10,000
Jun 02 2015	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Buy	J	0.00	504	0	1,333	829 to 1.3 K (+60.80 %)
Jun 02 2015	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Grant	A	0.00	1,357	0	10,034	8.7 K to 10 K (+15.64 %)
Jun 02 2015	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Sell	J	0.00	10,000	0	0	10 K to 0 (-100.00 %)
Jun 02 2015	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Buy	J	0.00	10,000	0	10,000	0 to 10 K
Jun 02 2015	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Sell	J	0.00	1,000,000	0	8,854,255	9.9 M to 8.9 M (-10.15 %)
Mar 10 2004	MEDI	MEDIMMUNE INC /DE	MOTT DAVID M	Vice Chairman and C ...	Option Exercise	A	23.45	750,000	17,587,500	750,000

Page: < prev 1 2